Insider holders · CIK 0000818033
HERON THERAPEUTICS, INC. /DE/ · HRTX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Savitr Capital, LLCrelationship not stated | 1,712,366 | — | 1,712,366 | Feb 12, 2015 · 4:35 pm EST | Form 5 |
| Craig A CollardChief Executive Officer | 856,492 | — | 856,492 | Aug 3, 2026 · 9:32 am EDT | Form 4 |
| Ira DuarteEVP, Chief Financial Officer | 281,899 | — | 281,899 | Aug 3, 2026 · 9:50 am EDT | Form 4 |
| William P ForbesEVP, Chief Development Officer | 241,173 | — | 241,173 | Aug 3, 2026 · 10:59 am EDT | Form 4 |
| Mark Earl HensleyChief Operating Officer | 170,901 | — | 170,901 | Aug 10, 2026 · 10:18 am EDT | Form 4 |
| Barry D QuartChief Executive Officer | 89,275 | — | 89,275 | Sep 14, 2018 · 11:41 am EDT | Form 4 |
| Andrew R Midlerrelationship not stated | — | 79,238 | 79,238 | Feb 12, 2015 · 2:04 pm EST | Form 5 |
| SPCH, LLCrelationship not stated | — | 79,238 | 79,238 | Feb 12, 2015 · 2:04 pm EST | Form 5 |
| TANG CAPITAL MANAGEMENT LLC10% Owner | 6,941 | 14,347 | 21,288 | Sep 12, 2018 · 12:28 pm EDT | Form 4 |
| TANG CAPITAL PARTNERS LP10% Owner | 6,941 | 14,347 | 21,288 | Sep 12, 2018 · 12:28 pm EDT | Form 4 |
| Kevin C TangDirector | 6,941 | 14,347 | 21,288 | Feb 14, 2019 · 4:02 pm EST | Form 5 |
| John PoyhonenDirector | 10,000 | — | 10,000 | Jan 23, 2017 · 4:29 pm EST | Form 4 |
| Brian G. DrazbaVP, Finance & CFO | 3,798 | — | 3,798 | Dec 23, 2016 · 4:03 pm EST | Form 4 |
| Robert RosenPresident | 2,640 | — | 2,640 | Jul 3, 2018 · 9:01 pm EDT | Form 4 |
| Paul MarshallSVP, Technical Operations | 2,200 | — | 2,200 | Mar 23, 2016 · 3:07 pm EDT | Form 4 |
| Robert HoffmanCFO & SVP, Finance | 1,280 | — | 1,280 | Jul 3, 2018 · 9:03 pm EDT | Form 4 |
| Waage ChristianDirector | 0 | — | 0 | Jun 23, 2016 · 10:28 am EDT | Form 3 |
| Neil James ClendeninnSVP & Chief Medical Officer | 0 | — | 0 | Oct 13, 2015 · 9:12 pm EDT | Form 3 |
| Kimberly ManhardExecutive VP, Drug Development | 0 | — | 0 | Nov 2, 2018 · 9:17 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.